Literature DB >> 16395389

Genetic analysis of susceptibility to Chlamydia trachomatis in mouse.

I Bernstein-Hanley1, Z R Balsara, W Ulmer, J Coers, M N Starnbach, W F Dietrich.   

Abstract

Chlamydia trachomatis is a bacterial pathogen that is a major cause of blindness and infertility in diverse populations across the world. In an effort to model genetic complexities that are observed in human populations and to identify novel genes involved in susceptibility to C. trachomatis, we have adapted a murine model of systemic infection for use in genetic analysis. In this model, chlamydial colonization and replication is measured in the spleens of mice shortly after intravenous delivery of C. trachomatis L2. Here, we show that C57BL/6J and C3H/HeJ inbred mice are differentially susceptible to this systemic infection. Additionally, fibroblasts cultured from C57BL/6J and C3H/HeJ embryos are differentially permissive for chlamydial replication. We have taken advantage of this natural variation to map quantitative trait loci on Chromosomes 2, 3, and 11 that segregate with the bacterial load in F2 cross progeny during the acute phase of C. trachomatis infection in vivo. To validate our mapping results, we also generated mice that are congenic for a portion of Chromosome 11 from the susceptible parent. This congenic interval confers increased susceptibility to C. trachomatis, both in vivo and in vitro, suggesting that our screen identified at least one gene that is involved in cellular resistance to C. trachomatis replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395389     DOI: 10.1038/sj.gene.6364285

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  29 in total

Review 1.  Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

Authors:  S Gruenheid; P Gros
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

Review 2.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

Authors:  Hossam Abdelsamed; Jan Peters; Gerald I Byrne
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

3.  An Excess of the Proinflammatory Cytokines IFN-γ and IL-12 Impairs the Development of the Memory CD8+ T Cell Response to Chlamydia trachomatis.

Authors:  Xuqing Zhang; Michael N Starnbach
Journal:  J Immunol       Date:  2015-07-15       Impact factor: 5.422

4.  Early Colonization of the Upper Genital Tract by Chlamydia muridarum Is Associated with Enhanced Inflammation Later in Infection.

Authors:  Jennifer D Helble; Nicole V Reinhold-Larsson; Michael N Starnbach
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

Review 5.  Animal models for studying female genital tract infection with Chlamydia trachomatis.

Authors:  Evelien De Clercq; Isabelle Kalmar; Daisy Vanrompay
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

Review 6.  Genetics-squared: combining host and pathogen genetics in the analysis of innate immunity and bacterial virulence.

Authors:  Jenny Persson; Russell E Vance
Journal:  Immunogenetics       Date:  2007-09-14       Impact factor: 2.846

7.  IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes.

Authors:  Si Ming Man; Rajendra Karki; Miwa Sasai; David E Place; Sannula Kesavardhana; Jamshid Temirov; Sharon Frase; Qifan Zhu; R K Subbarao Malireddi; Teneema Kuriakose; Jennifer L Peters; Geoffrey Neale; Scott A Brown; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

8.  Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.

Authors:  Thomas J Hannan; Indira U Mysorekar; Chia S Hung; Megan L Isaacson-Schmid; Scott J Hultgren
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

Review 9.  Interferon-Inducible GTPases in Host Resistance, Inflammation and Disease.

Authors:  Danielle Pilla-Moffett; Matthew F Barber; Gregory A Taylor; Jörn Coers
Journal:  J Mol Biol       Date:  2016-05-12       Impact factor: 5.469

10.  Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.

Authors:  Illya Tietzel; Christelle El-Haibi; Rey A Carabeo
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.